The present invention relates to proteinase-3 (PR3) as a target for stroke treatment. In detail, proteinase-3, which is a proteinase existing in great quantities in neutrophil, plays a significant role in damage to nerve cells of the brain and in inflammatory response to a stroke, and therefore may be used as a target for stroke treatment.
PROTEINASE-3 AS A TARGET FOR STROKE TREATMENT